Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction

Journal of Neuroscience Research

Volumn 87, Issue 10, 2009, Pages 2282-2289

  Zhang, Zhen ^a   Xia, Chunyi ^a   Xue, Yixue ^a   Liu, Yunhui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Blood tumor barrier; Bradykinin; Low frequency ultrasound; Permeability; Tight junction

Indexed keywords

BRADYKININ; CLAUDIN 5; OCCLUDIN; PROTEIN ZO1; DIAGNOSTIC AGENT; EVANS BLUE; MEMBRANE PROTEIN; PHOSPHOPROTEIN; VASODILATOR AGENT; ZONULA OCCLUDENS 1 PROTEIN; ZONULA OCCLUDENS-1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GLIOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TIGHT JUNCTION; ULTRASOUND; ANIMAL; BRAIN TUMOR; CAPILLARY PERMEABILITY; DIATHERMY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; METABOLISM; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRADYKININ; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; CELL LINE, TUMOR; DIATHERMY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EVANS BLUE; FEMALE; GLIOMA; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHOPROTEINS; RATS; RATS, WISTAR; TIGHT JUNCTIONS; VASODILATOR AGENTS;

EID: 69249219270     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22061     Document Type: Article

References (34)

1. Bartus RT, Elliott P, Hayward N, Dean R, McEwen EL, Fisher SK. 1996. Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system. Immunopharmacology 33:270-278.
2. Bullard DE, Bigner DD. 1984. Blood-brain barrier disruption in immature Fischer 344 rats. J Neurosurg 60:743-750.
3. Charlton ST, Whetstone J, Fayinka ST, Read KD, Illum L, Davis SS. 2008. Evaluation of direct transport pathways of glycine receptor antagonists and an Angiotensin antagonist from the nasal cavity to the central nervous system in the rat model. Pharm Res 25:1531-1543.
4. Choi JJ, Pernot M, Brown TR, Small SA, Konofagou EE. 2007. Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound. Phys Med Biol 52:5509-5530.
5. Demeule M, Currie JC, Bertrand Y, Ché C, Nguyen T, Régina A, Gabathuler R, Castaigne JP, Béliveau R. 2008. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2. J Neurochem 106:1534-1544.
6. Emerich DF, Dean RL, Osborn C, Bartus RT. 2001. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation. Clin Pharmacokinet 40:105-123.
7. Gu YT, Zhang H, Xue YX. 2007. Dexamethasone enhances adenosine 5′-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model. Brain Res 1162:1-8.
8. Guillemot L, Hammar E, Kaister C, Ritz J, Caille D, Jond L, Bauer C, Meda P, Citi S. 2004. Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression. J Cell Sci 117(Pt 22):5245-5256.
9. Hynynen K. 2008. Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev 60:1209-1217.
10. Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N. 2005. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24:12-20.
11. Inamura T, Nomura T, Bartus RT, Black KL. 1994. Intracaroid infusion of RMP-7, a bradykinin analog: a method for selective drug delievery to brain tumor. Neurosurge 81:752-758.
12. Kniesel U, Wolburg H. 2000. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 20:57-76.
13. Liu LB, Xue YX, Liu YH, Wang YB. 2008. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton. J Neurosci Res 86:1153-1168.
14. Lockman PR, Manda VK, Geldenhuys WJ, Mittapalli RK, Thomas F, Albayati ZF, Crooks PA, Dwoskin LP, Allen DD. 2008. Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n-dodecylbispicolinium dibromide at the blood-brain barrier. J Pharmacol Exp Ther 324:244-250.
15. Matsukado K, Inamura T, Nakano S, Fukui M, Bartus RT, Black KL. 1996. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 39:125-133.
16. McDannold N, Vykhodtseva N, Raymond S, Jolesz FA, Hynynen K. 2005. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol 31:1527-1537.
17. McDannold N, Vykhodtseva N, Hynynen K. 2008. Blood-brain barrier disruption induced by focused ultrasound and circulating performed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol 34:834-840.
18. Meairs S, Hennerici M. 2006. Future developments in neurovascular ultrasound. Front Neurol Neurosci 21:261-268.
19. Miebach S, Grau S, Hummel V, Rieckmann P, Tonn JC, Goldbrunner RH. 2006. Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades. J Neurooncol 76:39-48.
20. Ningaraj NS, Rao M, Hashizume K, Asotra K, Black KL. 2002. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels. J Pharmacol Exp Ther 301:838-851.
21. Nusrat A, Turner JR, Madara JL. 2000. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279:G851-G857.
22. Penna C, Mancardi D, Rastaldo R, Losano G, Pagliaro P. 2007. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res 75:168-177.
23. Prado GN, Taylor L, Zhou X, Ricupero D, Mierke DF, Polgar P. 2002. Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol 193: 275-286.
24. Raymond SB, Skoch J, Hynynen K, Bacskai BJ. 2007. Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo. J Cereb Blood Flow Metab 27:393-403.
25. Schürer L, Temesvari P, Wahl M, Unterberg A, Baethmann A. 1989. Blood-brain barrier permeability and vascular reactivity to bradykinin after pretreatment with dexamethasone. Acta Neuropathol 77:576-581.
26. Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. 2007. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 121:901-907.
27. Uchida M, Chen Z, Liu Y, Black KL. 2002. Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood-brain tumor barrier permeability increase. Neurol Res 24:739-746.
28. Wang M, Etu J, Joshi S. 2007a. Enhanced disruption of the blood brain barrier by intracaratid mannitol injection during transient cerebral hypoperfusion in rabbits. J Neurosurg Anesthesiol 19:249-256.
29. Wang YB, Peng C, Liu YH. 2007b. Low dose of bradykinin selectively increases intracellular calcium in glioma cells. J Neurol Sci 258:44-51.
30. Wolburg H, Lippoldt A. 2002. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol 38:323-337.
31. Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, Engelhardt B. 2003. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 105:586-592.
32. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK. 1994. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 54:4564-4568.
33. Zhang H, Gu YT, Xue YX. 2007. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 50-triphosphate-sensitive potassium channel. Brain Res 1144:33-41.
34. Zhang Z, Xia CY, Liu YH, Xue YX. 2008. Selective permeation of the blood-tumor barrier in rats by low frequency ultrasound treatment. Chinese J Ultrasound Med 24:581-584.